Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Glynet-PM2 Tablet ER
Zeelab Pharmacy Pvt Ltd
Pioglitazone 15mg
Pack Size
1 units
Price
Save ₹89
that's 79% off!
About This Medicine
Product description & overview
Genericart Glimepiride+Metformin+Pioglitazone Tablet SR: A Comprehensive Treatment for Type 2 Diabetes
This combination tablet contains Glimepiride (2mg), Metformin (500mg) and Pioglitazone (15mg), a carefully formulated dosage to effectively manage Type 2 Diabetes. Each medication in this blend works synergistically to lower blood sugar levels and improve insulin sensitivity, contributing to better glycemic control.
Glimepiride is a sulfonylurea, stimulating insulin release from the pancreas, while Metformin, an established Biguanide, enhances insulin activity and reduces hepatic glucose production. Finally, Pioglitazone is a Thiazolidinedione, increasing peripheral glucose uptake and decreasing hepatic glucose production, further contributing to blood sugar control.
These medications are often prescribed in combination for optimal results. This specific formulation offers convenience with its once-daily dosage and sustained-release technology (SR) ensuring consistent therapeutic effect throughout the day.
Please Note: Consult a physician before use as this product is not intended for self-treatment. This description provides general information and should not be considered a substitute for professional medical advice.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glimepiride
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR.
High Risk
Pregnancy
Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR may be needed. Please consult your doctor. Use of Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Genericart Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet SR
Products matching your search
Evoxil CV Kid Tablet
Evoxil CV Kid Tablet
Genericart Methylprednisolone 8mg Tablet
Genericart Methylprednisolone 8mg Tablet
Eternex-M 500 Tablet SR
Eternex-M 500 Tablet SR
Esomac 40 Tablet
Esomac 40 Tablet
Glix MR 60 Tablet
Glix MR 60 Tablet
Genericart Nicorandil 5mg Tablet
Genericart Nicorandil 5mg Tablet
Combihale FB Forte DPI Capsule
Combihale FB Forte DPI Capsule
Glucomine Trio Tablet